Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469274 · ClinicalTrials.gov registry record · NA
Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 1,102
- Enrollment target
NCT00469274 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 1,102 participants.
The verdict
NCT00469274, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,102 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two strategies of post-exposure prophylaxis (PEP) in healthcare workers (HCWs) who have been vaccinated with acellular pertussis vaccine and have been exposed to pertussis Secondary Objectives include a comparison of the costs of each PEP strategy and an assessment for risk factors associated with healthcare-associated acquisition of pertussis.
Interventions
- DRUG Antibiotic PEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,102 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00469274
The ClinicalTrials.gov registry entry for NCT00469274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Antibiotic PEP is the first listed.
NCT00469274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00469274 about?
NCT00469274 is a clinical study titled "Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure". The purpose of this study is to compare the effectiveness of two strategies of post-exposure prophylaxis (PEP) in healthcare workers (HCWs) who have been vaccinated with acellular pertussis vaccine and have been exposed to pertussis Secondary Objectives include a comparison of the costs of each PEP ...
What is the current status of trial NCT00469274?
This trial is currently completed. It is a NA study. The enrollment target is 1,102 participants. The study started on 2007-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00469274?
The interventions under investigation include: Antibiotic PEP (DRUG).
Who is sponsoring clinical trial NCT00469274?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.